Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a report released on Tuesday. The brokerage issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright reiterated a “buy” rating and set a $7.00 target price on shares of Aethlon Medical in a research report on Friday, November 15th.

Aethlon Medical Stock Performance

Shares of NASDAQ AEMD opened at $0.37 on Tuesday. Aethlon Medical has a one year low of $0.24 and a one year high of $2.35. The business has a fifty day simple moving average of $0.39 and a 200 day simple moving average of $0.42. The firm has a market capitalization of $5.11 million, a price-to-earnings ratio of -0.13 and a beta of 1.79.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.